期刊
MOLECULAR INFORMATICS
卷 37, 期 1-2, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/minf.201700153
关键词
Automation; drug discovery; machine learning; medicinal chemistry; nuclear receptor
类别
资金
- Swiss National Science Foundation [IZSEZ0_177477]
- ETH Zurich Postdoctoral Fellowship [16-2 FEL-07]
Generative artificial intelligence offers a fresh view on molecular design. We present the first-time prospective application of a deep learning model for designing new druglike compounds with desired activities. For this purpose, we trained a recurrent neural network to capture the constitution of a large set of known bioactive compounds represented as SMILES strings. By transfer learning, this general model was fine-tuned on recognizing retinoid X and peroxisome proliferator-activated receptor agonists. We synthesized five top-ranking compounds designed by the generative model. Four of the compounds revealed nanomolar to low-micromolar receptor modulatory activity in cell-based assays. Apparently, the computational model intrinsically captured relevant chemical and biological knowledge without the need for explicit rules. The results of this study advocate generative artificial intelligence for prospective de novo molecular design, and demonstrate the potential of these methods for future medicinal chemistry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据